Jess W. Sager

Statistics

Publications

Citations

445

H-Index

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Jess W. Sager is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in synthetic medicinal chemistry, medicinal chemistry, and chemistry.

Publications per year

1995–2002

Publications

Highly Regioselective Friedländer Annulations with Unmodified Ketones Employing Novel Amine Catalysts: Syntheses of 2-Substituted Quinolines, 1,8-Naphthyridines, and Related Heterocycles

Peter G. Dormer, Kan K. Eng, Roger N. Farr et al. · The Journal of Organic Chemistry · 2002 · 132 citations

Natural Sciences, Chemistry, Medicinal Chemistry +17

Asymmetric hydrogenation of tetrahydropyrazines: Synthesis of (S)-piperazine-2-tert-butylcarboxamide, an intermediate in the preparation of the HIV protease inhibitor indinavir

Kai Rossen, Steven A. Weissman, Jess W. Sager et al. · Tetrahedron Letters · 1995 · 113 citations

Pharmacy, Chemistry, Medicinal Chemistry +14

Synthesis of the orally active spiroindoline-based growth hormone secretagogue, MK-677

Peter E. Maligres, Ioannis N. Houpis, Kai Rossen et al. · Tetrahedron · 1997 · 49 citations

Medicine, Medicinal Chemistry, Pharmacology +12

An efficient and versatile synthesis of piperazine-2-carboxamides

Kai Rossen, Jess W. Sager, Lisa DiMichele · Tetrahedron Letters · 1997 · 49 citations

Pharmacy, Chemistry, Medicinal Chemistry +5

A practical synthesis of 5‐(chloromethyl)furo[2,3‐<i>b</i>]pyridine, a key intermediate for the HIV protease inhibitor, L‐754,394

M. Bhupathy, David A. Conlon, Kenneth M. Wells et al. · Journal of Heterocyclic Chemistry · 1995 · 33 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10

1–5 of 8